Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Standard Therapy + Manual Accupressure: Intranasal corticosteroid and Oral antihistamine + Self administered manual acupressure to 5 points for 6 weeks
Control Intervention1: Intranasal
Sponsors
JIPMER Intramural Research Fund
Eligibility
Inclusion criteria
Inclusion criteria: 1. Between the ages of 18 and 50 years 2. Clinically diagnosed as allergic rhinitis, as per ARIA guidelines and using Absolute Eosinophil Count 3. Symptom duration for more than 6 months 4. Moderate to severe allergic rhinitis (Visual Analogue Scale score of 30-70mm at baseline) 5. Symptoms severe enough to require oral antihistamines/intranasal corticosteroid usage
Exclusion criteria
Exclusion criteria: 1. Pediatric patients, less than 18 years of age 2. Patients with anatomical abnormality of nose (Deviated nasal septum, Concha bullosa etc) 3. Patients with diagnosed asthma or other chronic upper respiratory pathologies, parasitic infestations or immunological diseases 4. Pregnant and breastfeeding women 5. Patients on steroids or other immunosuppressive therapy for unrelated conditions 6. Patients using other complementary medicine systems during the study period 7. Contra-indication to cetirizine or inhalational steroid therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in scores of quality of life questionnaires: NRQLQ, VAS, TNSSTimepoint: Improvement in scores of quality of life questionnaires: NRQLQ, VAS, TNSS at baseline, 4 weeks and 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in total serum human immunoglobulin E (IgE)Timepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactKalaiarasi Raja
JIPMER
Outcome results
None listed